CondomDepot.com drops N-9
This article was originally published in The Tan Sheet
Executive Summary
CondomDepot.com claims to be the first major condom retailer to stop selling products containing the spermicide nonoxynol-9 in Feb. 26 announcement. "Studies prove that the small amount of nonoxynol-9 used on condoms has been declared ineffective as a contraceptive and does not substantially decrese the incidence of pregnancy," CondomDepot.com president Kimberly Fidi states. "Condoms alone are 98% effective when used properly," she adds. Concern surrounding N-9's use is due in part to a 2002 World Health Organization report that the spermicide was an irritant and could possibly facilitate HIV transmission and other sexually transmitted diseases (1"The Tan Sheet" July 8, 2002, p. 17)...
You may also be interested in...
N-9 Data Warrants Spermicide Safety Study, WHO Report Recommends
The safety of all spermicides should be evaluated in light of recent research indicating the one-time top microbicide candidate nonoxynol-9 actually causes lesions that may facilitate transmission of HIV and other sexually transmitted infections, according to the final report of a "Technical Consultation on N-9," released June 25
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.